Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
768,300
-
Total 13F shares
-
405,570
-
Share change
-
+224,264
-
Total reported value
-
$186,762
-
Price per share
-
$0.47
-
Number of holders
-
18
-
Value change
-
+$101,602
-
Number of buys
-
11
-
Number of sells
-
7
Institutional Holders of Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD) as of Q3 2024
As of 30 Sep 2024,
Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
405,570 shares.
The largest 10 holders included
UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Baader Bank Aktiengesellschaft, TWO SIGMA INVESTMENTS, LP, TWO SIGMA SECURITIES, LLC, Tower Research Capital LLC (TRC), BlackRock, Inc., CITIGROUP INC, and JPMORGAN CHASE & CO.
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.